The EMBO Journal
 
Advanced search
Journal home
Current issue
Advance Online Publication
Web Focuses
Archive
Browse by subject
Free online sample issue
Aims and scope
Press releases
ToC by email
Authors & Referees
Guide for authors
Submit an Article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
Subject Categories: Differentiation & Death | Molecular Biology of Disease
The EMBO Journal (2007) 26, 2732–2742, doi:10.1038/sj.emboj.7601703
Published online 3 May 2007
BRCA2 is required for neurogenesis and suppression of medulloblastoma
Pierre-Olivier Frappart, Youngsoo Lee, Jayne Lamont and Peter J McKinnon
Department of Genetics and Tumor Cell Biology, St Jude Children's Research Hospital, Memphis, TN, USA

To whom correspondence should be addressed
Peter J McKinnon, Department of Genetics and Tumor Cell Biology, St Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105, USA. Tel.: +1 901 495 2700; Fax: +1 901 526 2907; E-mail: peter.mckinnon@stjude.org

Received 13 November 2006; Accepted 5 April 2007; Published online 3 May 2007.
Abstract
Defective DNA damage responses in the nervous system can result in neurodegeneration or tumorigenesis. Despite the importance of DNA damage signalling, the neural function of many critical DNA repair factors is unclear. BRCA2 is necessary for homologous recombination repair of DNA and the prevention of diseases including Fanconi Anemia and cancer. We determined the role of BRCA2 during brain development by inactivating murine Brca2 throughout neural tissues. In striking contrast to early embryonic lethality after germ-line inactivation, Brca2LoxP/LoxP;Nestin-cre mice were viable. However, Brca2 loss profoundly affected neurogenesis, particularly during embryonic and postnatal neural development. These neurological defects arose from DNA damage as Brca2LoxP/LoxP;Nestin-cre mice showed extensive gammaH2AX in neural tissue and p53 deficiency restored brain histology but lead to rapid formation of medulloblastoma brain tumors. In contrast, loss of the Atm kinase did not markedly attenuate apoptosis after Brca2 loss, but did partially restore cerebellar morphology, supporting a genomic surveillance function for ATM during neurogenesis. These data illustrate the importance of Brca2 during nervous system development and underscore the tissue-specific requirements for DNA repair factors.
Keywords: ATM, BRCA2, homologous recombination, medulloblastoma, neurogenesis
Top

MORE ARTICLES LIKE THIS

Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2007 by the European Molecular Biology Organization